ArticleFrontiers in immunology2026

PRaG5.0 combined with chemotherapy and sequential chemoimmunotherapy for massive SMARCA4-deficient undifferentiated tumor of the cervix: case report.

Zixin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.